Suite la dclaration deffets indsirables auprs du dispositif national de nutrivigilance, lAgence nationale de scurit sanitaire de lalimentation, de lenvironnement et du travail (Anses) dconseille la prise de complments alimentaires en vue de dvelopper la masse musculaire ou de diminuer la masse grasse (parmi lesquels ceux contenant de la carnitine) aux enfants et aux adolescents, ainsi quaux adultes prsentant des facteurs de risque cardio-vasculaire (antcdents chez les parents ou dans la fratrie, hypertension artrielle, tabagisme) ou souffrant dune maladie cardiaque, rnale, du foie ou psychiatrique
7 Table 1 describes the estimated absolute difference in outcomes with SGLT-2 inhibitors and GLP-1 receptor agonists compared with placebo per 1,000 people with type 2 diabetes with moderate or very high cardiovascular risk
Results from these studies have shown that RGT-075 is generally safe and well tolerated, while preliminary efficacy data suggest its therapeutic potential may be comparable to currently approved peptide-based GLP-1 therapies
Pace your dose increases carefully: moving from 0.25 mg to 0.5 mg per week gives your body four weeks to adjust, lowering dizziness risk compared to faster escalation
